Centre for Biomedical Ethics, Yong Loo Lin School of Medicine, National University of Singapore, Block MD 11 #02-03, 10 Medical Drive, Singapore, 117597, Singapore.
J Assist Reprod Genet. 2017 Dec;34(12):1577-1580. doi: 10.1007/s10815-017-1046-8. Epub 2017 Sep 18.
With the recent report of a live birth after use of mitochondrial replacement therapy, sometimes called 'three-parent IVF', the clinical application of the technique is fast becoming a reality. While the United Kingdom allows the procedure under regulatory scrutiny, it remains effectively outlawed in many other countries. We argue that such prohibitions may violate individuals' procreative rights, grounded in individuals' interest in genetic affinity. The interest in genetic affinity was recently endorsed by Singapore's highest court, reflecting an emphasis on the importance of biological ties found across the globe. We apply that reasoning to make the case for a right to 'three-parent IVF'.
随着最近一份使用线粒体替代疗法（有时称为“三亲 IVF”）后诞生活婴的报告的发布，该技术的临床应用正迅速成为现实。虽然英国在监管审查下允许该程序，但在许多其他国家，该程序实际上仍被禁止。我们认为，这种禁止可能侵犯了个人的生育权利，这些权利基于个人对遗传亲和力的利益。遗传亲和力的利益最近得到了新加坡最高法院的认可，反映了全球范围内对生物联系重要性的重视。我们运用这一推理来论证“三亲 IVF”的权利。
